Naftifine Hydrochloride (Taro Pharmaceuticals U.S.A., Inc.)
Welcome to the PulseAid listing for the Naftifine Hydrochloride drug offered from Taro Pharmaceuticals U.S.A., Inc.. This Allylamine [Chemical/Ingredient],Allylamine Antifungal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Taro Pharmaceuticals U.S.A., Inc. |
| NON-PROPRIETARY NAME: | Naftifine Hydrochloride |
| SUBSTANCE NAME: | NAFTIFINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Allylamine [Chemical/Ingredient],Allylamine Antifungal [EPC] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-09-08 |
| END MARKETING DATE: | 0000-00-00 |
Naftifine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Naftifine Hydrochloride from Taro Pharmaceuticals U.S.A., Inc. |
| LABELER NAME: | Taro Pharmaceuticals U.S.A., Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/g) |
| START MARKETING DATE: | 2016-09-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51672-1362_e251d16a-efe7-4da8-840d-f524d0c228e8 |
| PRODUCT NDC: | 51672-1362 |
| APPLICATION NUMBER: | ANDA205975 |
Other NAFTIFINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
